AMWL
American Well Corporation - Ordinary Shares - Class A

3,548
Mkt Cap
$89.97M
Volume
90,656.00
52W High
$12.95
52W Low
$5.32
PE Ratio
-0.69
AMWL Fundamentals
Price
$5.60
Prev Close
$5.57
Open
$5.64
50D MA
$6.41
Beta
1.62
Avg. Volume
69,241.95
EPS (Annual)
-$13.88
P/B
0.32
Rev/Employee
$290,038.77
Loading...
Loading...
News
all
press releases
Hims & Hers Advances AI-Powered Personalized Digital Healthcare
HIMS accelerates AI-powered care with new tech leadership, personalized treatments and a major $870 million investment push.
Zacks·5d ago
News Placeholder
More News
News Placeholder
Hims & Hers Gains 3.8% in 3 Months: Time to Hold the Stock or Sell?
HIMS expands into men's health and hormones, but rising costs and regulatory hurdles threaten its momentum.
Zacks·13d ago
News Placeholder
Hims & Hers Expands Health Access Through Subscription Revenue Model
HIMS boosts predictable revenue and customer loyalty with a flexible, subscription-based model across key health categories.
Zacks·24d ago
News Placeholder
From Apps to Nutrition: Health & Fitness Stocks to Buy Now
UNFI, AMWL, STKL, and PTON stand out as health and fitness plays, tapping into booming demand for wellness, nutrition and digital care.
Zacks·24d ago
News Placeholder
Hims & Hers Surges 64.1% in 6 Months: How to Play the Stock?
HIMS accelerates with new men's health launches, global expansion plans and strong subscriber-driven growth, but rising costs strain gross margins.
Zacks·2mo ago
News Placeholder
Hims & Hers Expanding Partnerships to Build a Global Health Ecosystem
HIMS expands its digital health footprint with global moves, top-tier partnerships and more than 1,500 providers.
Zacks·2mo ago
News Placeholder
HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy?
Hims & Hers expands globally, while Amwell leans on federal contracts and software growth. Let's see which has the edge in earnings growth & strategic expansion.
Zacks·2mo ago
News Placeholder
Hims & Hers Fuels Growth via Market Expansion and New Care Verticals
HIMS eyes long-term growth with new hormonal health offerings, international expansion and high GLP-1 retention.
Zacks·2mo ago
News Placeholder
Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit?
HIMS records subscriber surge and revenue growth in second-quarter 2025, but rising costs strain gross margins.
Zacks·3mo ago
News Placeholder
American Well (AMWL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for American Well (AMWL) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·3mo ago

Latest AMWL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.